Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 33Unknown 10Terminated 6Recruiting 6Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Plasma cell 3Dermatologic 2Myeloid 1Lymphoid 1Classical hematology 1CNS 1Breast 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 21Magnetic Resonance Spectroscopy 9Radiotherapy 8Blood Specimen Collection 8Cyclophosphamide 6Bevacizumab 6AZD 6244 6pembrolizumab 5Specimen Handling 4Radiation 4fludarabine 3dinutuximab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3vorasidenib 2tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2cemiplimab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Melphalan × CNS × Clear all
NCT05303727 2022-07-01

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
64 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡